Qube Research & Technologies (QRT)’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Buy |
171,424
+16,807
| +11% | +$315K | ﹤0.01% | 1429 |
|
|
2025
Q1 | $2.78M | Buy |
154,617
+36,660
| +31% | +$660K | ﹤0.01% | 1433 |
|
|
2024
Q4 | $1.98M | Buy |
+117,957
| New | +$1.98M | ﹤0.01% | 1496 |
|
|
2024
Q3 | – | Sell |
-17,667
| Closed | -$145K | – | 3446 |
|
|
2024
Q2 | $145K | Buy |
17,667
+8,596
| +95% | +$70.7K | ﹤0.01% | 2168 |
|
|
2024
Q1 | $134K | Buy |
+9,071
| New | +$134K | ﹤0.01% | 2725 |
|
|
2023
Q4 | – | Sell |
-12,433
| Closed | -$134K | – | 4151 |
|
|
2023
Q3 | $134K | Sell |
12,433
-2,648
| -18% | -$28.6K | ﹤0.01% | 2140 |
|
|
2023
Q2 | $195K | Sell |
15,081
-32,256
| -68% | -$416K | ﹤0.01% | 1714 |
|
|
2023
Q1 | $625K | Buy |
+47,337
| New | +$625K | ﹤0.01% | 1417 |
|
|
2022
Q4 | – | Sell |
-57,661
| Closed | -$680K | – | 2839 |
|
|
2022
Q3 | $680K | Buy |
+57,661
| New | +$680K | ﹤0.01% | 1305 |
|
|
2022
Q2 | – | Sell |
-11,201
| Closed | -$335K | – | 3016 |
|
|
2022
Q1 | $335K | Buy |
11,201
+919
| +9% | +$27.5K | ﹤0.01% | 1708 |
|
|
2021
Q4 | $272K | Sell |
10,282
-863
| -8% | -$22.8K | ﹤0.01% | 1848 |
|
|
2021
Q3 | $405K | Buy |
11,145
+9,208
| +475% | +$335K | 0.01% | 1331 |
|
|
2021
Q2 | $84K | Sell |
1,937
-7,182
| -79% | -$311K | ﹤0.01% | 1965 |
|
|
2021
Q1 | $312K | Buy |
9,119
+4,975
| +120% | +$170K | ﹤0.01% | 1434 |
|
|
2020
Q4 | $145K | Buy |
+4,144
| New | +$145K | ﹤0.01% | 1587 |
|